NewsSource: EClinCloud

Product Introduction | RTSM · Randomization and Trial Supply Management System

3 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration


With advances in technology and national regulatory requirements and encouragement, the shift toward electronic clinical research has become the future trend for clinical trials. Web-based randomization and drug supply management systems are being used in a growing number of clinical trials, and randomization and control, as fundamental principles of clinical trials, are widely applied in efficacy and safety evaluations. An RTSM system is of great significance for improving both the efficiency and quality of clinical trials.


What Is EClinCloud RTSM?


The full name of the EClinCloud RTSM system is Randomization and Trial Supply Management, a next-generation randomization and trial supply management system designed for multicenter subject randomization and drug supply management. It can effectively manage multicenter clinical trials with large numbers of subjects and address pain points in drug dispensing and drug management.


The EClinCloud RTSM system integrates functional modules for randomization schemes, treatment regimens, subject management, and drug supply plan management. It supports a range of complex randomization schemes and trial designs, providing investigators with an efficient, secure, and convenient system tool for randomized trials and drug management.


 What Are the Features of the EClinCloud RTSM System?



01 Flexible and Precise Randomization Scheme Configuration

  • Includes multiple built-in randomization algorithms and blinding settings, supports multi-segment block configurations and real-time capture of stratification factors, and accurately reproduces allocation tables

  • When a user uploads an allocation table, the system rapidly reverse-engineers the scheme configuration based on the file contents



02 Diverse Treatment Regimen Design

  • Four-in-one treatment regimen design that supports multi-visit dosing and multi-regimen allocation, as well as data capture and multi-factor configuration for drug dosage factors



03 Clear Subject Management

  • Supports subject management operations within the subject management module, including drug dispensing, unblinding, data export, and open-label treatment



04 End-to-End Drug Supply Plan Management

  • Supports full-lifecycle drug control across bidirectional dimensions, with configurable smart plan comparison and early-warning alert functions



 What Are the Advantages of EClinCloud RTSM?


01

Effectively Curbs Human Intervention to Safeguard Study Safety and Authenticity

The system incorporates multiple built-in randomization algorithms and blinding settings to ensure balance across treatment groups, effectively curb human intervention, and enhance the objectivity, safety, authenticity, and credibility of the study.

Article illustration


Article illustration


02

Clean, User-Friendly Interface with Clear Workflow Logic

The system's functional modules are designed to align with real-world workflows, offering convenient configuration and rapid responsiveness to protocol requirements.

Article illustration



03

Closed-Loop Drug Management Integrating Supply and Control

Provides full-lifecycle drug control across bidirectional dimensions, supporting smart plan comparison and early-warning alerts.

Article illustration



04

Adaptable to Multiple Application Scenarios with High Flexibility

Supports inter-system integration and data interoperability, while also supporting subject drug dispensing operations and status management when used standalone.

Article illustration



05

Robust Data Security

Granular user permission configuration down to the module and function level; a comprehensive data security system and SOP system certification; and thorough technical solutions for data security across both production and R&D environments.

Article illustration



What Services Does EClinCloud Provide?


Provides Users with Comprehensive System Operation Training and Qualification Certification
Provides Study Build Services
Provides End-to-End Project Management






About EClinCloud

EClinCloud is a technology company focused on clinical research and development. It provides an integrated, interoperable, all-in-one clinical trial cloud platform (including technology products such as eCOA, CTMS, eTMF, EDC, and RTSM, as well as solutions such as scale management, linguistic validation, rater training, and data quality analysis) and clinical trial endpoint assessment technologies across therapeutic areas (including oncology, central nervous system, ophthalmology, and others). Combining cutting-edge technology with life-science data, it builds a globally leading "patient-centric" SaaS cloud platform for clinical evidence to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the launch of drugs and medical devices, and benefit countless patients.




Article illustration

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.